US 12037411
Antibodies, and bispecific antigen-binding molecules that bind HER2 and/or APLP2, conjugates, and uses thereof
granted A61KA61K2039/505A61K47/6849
Quick answer
US patent 12037411 (Antibodies, and bispecific antigen-binding molecules that bind HER2 and/or APLP2, conjugates, and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505, A61K47/6849, A61K47/6855, A61K47/6879